Discover Opportunities. Start Here
The spring of 2026, traditionally heralded as the most vibrant period for residential real estate transactions, finds itself in an unexpected and precarious position. While early indicators and prevailing sentiment…
The journey of building a tech startup is often fraught with challenges, a reality familiar to many founders. For Kyle Law, the experience was particularly illuminating, not just for the…
FedEx Corporation (NYSE: FDX) on Thursday delivered a stellar performance for its fiscal third quarter, significantly surpassing Wall Street’s expectations for both earnings and operational income. The global logistics giant…
In a pivotal move set to dramatically reshape the intensely competitive landscape of obesity therapeutics, the U.S. Food and Drug Administration (FDA) on Thursday granted approval for a higher-dose version…
The tragic story of Amaurie Lacey, a 17-year-old who died by suicide last June, has become a focal point in a burgeoning legal challenge against artificial intelligence companies like OpenAI.…
Los Angeles, California – Uber Technologies, the global ride-hailing and food delivery giant, has announced a landmark agreement to invest up to $1.25 billion in electric vehicle manufacturer Rivian Automotive.…
Paris, France – Advanced Machine Intelligence (AMI), a nascent artificial intelligence startup co-founded by AI luminary Yann LeCun, has announced a monumental funding round, raising over $1 billion to propel…
The AI technology startup Anthropic is embroiled in a significant legal dispute with the U.S. government, stemming from sanctions imposed by the Trump administration. In its first court hearing challenging…
Johnson & Johnson announced on Wednesday, October 10, 2025, that the U.S. Food and Drug Administration (FDA) has granted approval for its groundbreaking once-daily psoriasis pill, Icotyde. This landmark decision…
The Trump administration, through its Department of Justice, has mounted a vigorous defense against a lawsuit filed by AI developer Anthropic, asserting that designating the company as a "supply-chain risk"…
